Viking Therapeutics faces pressure after mixed oral obesity pill trial results, raising safety concerns but still meeting key ...

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

Novo Nordisk, facing competition in the obesity drug market, has instructed employees to return to the office to enhance ...

Novo Nordisk has mandated a return to office work for all staff to speed up decision-making and improve market execution, ...

Consumer prices rose 2.9% in August from a year earlier, the Labor Department said Tuesday, the biggest increase since ...

This Denmark-headquartered company underestimated demand for its anti-obesity treatment Wegovy when it launched in the U.S.

Novo Nordisk, the Danish pharmaceutical giant behind the blockbuster obesity drug Wegovy, has announced a sweeping ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...

Novo, which has 78,400 positions globally, said about 5,000 of the job cuts will be in its native Denmark. Read more at ...

There are fears Denmark is facing a so-called “Nokia risk”. Read more at straitstimes.com. Read more at straitstimes.com.

The company downgraded its guidance for the second time in six weeks as it announced a restructuring plan.